KYBELLA™ is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin." It is not known if KYBELLA™ is safe and effective for use outside of the submental area.
Submental fullness, sometimes referred to as “double chin”, is a common yet undertreated facial aesthetic condition. It can impact a broad range of adults, including both men and women, and can be influenced by several factors such as aging, genetics, and weight gain, and is often resistant to diet and exercise alone.
If you’re bothered by submental fullness, you’re not alone. According to a 2014 survey conducted by the American Society for Dermatologic Surgery (ASDS):
The active ingredient in KYBELLA™ is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
When injected into the fat beneath your chin, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
You and your doctor will decide how many treatments you need. Once the desired aesthetic response is achieved with KYBELLA™, retreatment is not expected.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you take a medicine that prevents the clotting of your blood (antiplatelet or anticoagulant medicine).
Injectables
KYBELLA™ (deoxycholic acid) injection is the first and only FDA-approved nonsurgical treatment that contours and improves the appearance of submental fullness, sometimes referred to as “double chin”.
You and your doctor will design a customized treatment plan to help you improve your chin profile. Many patients experience visible contouring of their chin profile in two to four treatment sessions spaced at least one month apart. Up to 6 treatments may be administered.
KYBELLA™ has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with KYBELLA™.
In the pivotal Phase III clinical trials:
68.2% of patients responded to KYBELLA™, compared to 20.5% of patients who responded to placebo, based on validated physician and patient measurements
79% of patients treated with KYBELLA™ reported satisfaction with the appearance of their face and chin
After being treated with KYBELLA™, patients reported improvement in self-perception, including feeling happier and younger based on their chin profile, as well as feeling less embarrassed, less self-conscious, less overweight and less bothered by submental fullness
KYBELLA™ can cause serious side effects, including trouble swallowing or nerve injury in the jaw that can cause an uneven smile or facial muscle weakness. The most common side effects of KYBELLA™ include: swelling, bruising, pain, numbness, redness and areas of hardness in the treatment area
KYBELLA™ is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called, “double chin.” It is not known if KYBELLA™ is safe and effective in children less than 18 years of age. It is not known if KYBELLA™ is safe and effective for use outside of the submental area.
Deoxycholic acid injection, for subcutaneous use.
KYBELLA™ (deoxycholic acid) injection is the first and only FDA-approved prescription nonsurgical treatment that is used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called, “double chin.” It is not known if KYBELLA™ is safe and effective in children less than 18 years of age. It is not known if KYBELLA™ is safe and effective for use outside of the submental area.
The active ingredient in KYBELLA™ is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
When injected into the fat beneath your chin, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat.
Only you and your doctor can decide if KYBELLA™ is right for you. If you’re bothered by submental fullness, or double chin, ask your doctor about KYBELLA™.
KYBELLA™ has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with KYBELLA™.
You and your doctor will customize your KYBELLA™ treatment regimen, including how many treatments you need, based on your desired chin profile. Your doctor will give you a series of injections at each treatment session, which are spaced a month or more apart. Many patients experience visible contouring of their chin profile in two to four treatment sessions spaced at least one month apart. Up to 6 treatments may be administered.
The safety profile of KYBELLA™ is well characterized. The most common side effects are swelling, bruising, pain, numbness, redness and areas of hardness around the treatment area. KYBELLA™ can cause serious side effects, including trouble swallowing and nerve injury in the jaw that can cause an uneven smile or facial muscle weakness. These are not all of the possible side effects of KYBELLA™. Call your healthcare provider for medical advice about side effects.
You and your doctor will customize your KYBELLA™ treatment regimen, including how many treatments you need, based on your desired chin profile. Your doctor will give you a series of injections at each treatment session, which are spaced a month or more apart. Many patients experience visible contouring of their chin profile in two to four treatment sessions spaced at least one month apart. Up to 6 treatments may be administered.
When injected into the fat under your chin, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment with KYBELLA™ is not expected.
